AVTR stock icon

Avantor
AVTR

$20.80
2.3%
 

About: Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.

Employees: 14,500

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 14 analysts
0
News positive %
of 6 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

51% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 41

27% more repeat investments, than reductions

Existing positions increased: 201 | Existing positions reduced: 158

17% more funds holding in top 10

Funds holding in top 10: 12 [Q4 2023] → 14 (+2) [Q1 2024]

10% more capital invested

Capital invested by funds: $14.8B [Q4 2023] → $16.3B (+$1.46B) [Q1 2024]

5% more funds holding

Funds holding: 455 [Q4 2023] → 476 (+21) [Q1 2024]

1.58% less ownership

Funds ownership: 95.35% [Q4 2023] → 93.77% (-1.58%) [Q1 2024]

86% less call options, than puts

Call options by funds: $43.3M | Put options by funds: $316M

Research analyst outlook

14 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$23
11%
upside
Avg. target
$27
30%
upside
High target
$30
44%
upside

14 analyst ratings

12 positive
86%
neutral
14%
negative
0%
Citigroup
Patrick Donnelly
11%upside
$23
Neutral
Downgraded
10 Jul 2024
Evercore ISI Group
Vijay Kumar
30%upside
$27
Outperform
Maintained
2 Jul 2024
Barclays
Luke Sergott
20%upside
$25
Overweight
Maintained
28 Jun 2024
Baird
Catherine Schulte
25%upside
$26
Outperform
Maintained
29 Apr 2024
Deutsche Bank
Justin Bowers
20%upside
$25
Hold
Maintained
18 Apr 2024

Financial journalist opinion

Based on 6 articles about AVTR published over the past 30 days